Compile Data Set for Download or QSAR
maximum 50k data
Found 433 for UniProtKB: Q9BQ51
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479542(US10899735, No. 1)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479966(US10899735, No. 425)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479578(US10899735, No. 37)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479553(US10899735, No. 12)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479963(US10899735, No. 422)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479958(US10899735, No. 417)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479950(US10899735, No. 409)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479870(US10899735, No. 329 | US10899735, No. 330)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479780(US10899735, No. 239)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479759(US10899735, No. 218)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479747(US10899735, No. 206)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479737(US10899735, No. 196)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479691(US10899735, No. 150)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479690(US10899735, No. 149)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479689(US10899735, No. 148)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479684(US10899735, No. 143)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479666(US10899735, No. 125)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479654(US10899735, No. 113)
Affinity DataIC50:  64nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479766(US10899735, No. 225)
Affinity DataIC50:  65nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479657(US10899735, No. 116)
Affinity DataIC50:  67nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479810(US10899735, No. 269)
Affinity DataIC50:  67nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479658(US10899735, No. 117)
Affinity DataIC50:  70nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479675(US10899735, No. 134)
Affinity DataIC50:  71nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479770(US10899735, No. 229)
Affinity DataIC50:  74nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479781(US10899735, No. 240)
Affinity DataIC50:  75nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479647(US10899735, No. 106)
Affinity DataIC50:  79nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479656(US10899735, No. 115)
Affinity DataIC50:  84nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479697(US10899735, No. 156 | US10899735, No. 306)
Affinity DataIC50:  86nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479668(US10899735, No. 127)
Affinity DataIC50:  87nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479655(US10899735, No. 114)
Affinity DataIC50:  88nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479645(US10899735, No. 104)
Affinity DataIC50:  90nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479735(US10899735, No. 194)
Affinity DataIC50:  91nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479667(US10899735, No. 126)
Affinity DataIC50:  92nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479736(US10899735, No. 195)
Affinity DataIC50:  93nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479636(US10899735, No. 95)
Affinity DataIC50:  94nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479785(US10899735, No. 244)
Affinity DataIC50:  95nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479548(US10899735, No. 7)
Affinity DataIC50:  100nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479856(US10899735, No. 315 | US10899735, No. 318)
Affinity DataIC50:  107nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479646(US10899735, No. 105)
Affinity DataIC50:  107nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479609(US10899735, No. 68)
Affinity DataIC50:  108nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479943(US10899735, No. 402)
Affinity DataIC50:  108nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479823(US10899735, No. 282)
Affinity DataIC50:  109nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479845(US10899735, No. 304)
Affinity DataIC50:  110nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479800(US10899735, No. 259)
Affinity DataIC50:  111nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479788(US10899735, No. 247)
Affinity DataIC50:  115nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479846(US10899735, No. 305)
Affinity DataIC50:  118nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479565(US10899735, No. 24)
Affinity DataIC50:  118nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479773(US10899735, No. 232)
Affinity DataIC50:  121nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479959(US10899735, No. 418)
Affinity DataIC50:  126nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand 1/2(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM479617(US10899735, No. 76)
Affinity DataIC50:  127nMAssay Description:Compounds were tested in biochemical protein-protein interaction assays to determine if they can specifically block the interaction between the extra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 433 total ) | Next | Last >>
Jump to: